http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-102057-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13a08b1e4a1519e4cb584ea6103d7188 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J3-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0038 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 |
| filingDate | 1987-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d877b49863577476da84f3b9956fed5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7e20c125a03cfaeea15914bbc1026e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb129de472d7725a025457e70b0d73cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed2560155fdc77b0f422e886e2b33da0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17d22e6929fa41a1e62c32adbbe07586 |
| publicationDate | 1992-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MY-102057-A |
| titleOfInvention | Novel androstane-17b-carboxylic acid esters |
| abstract | THE INVENTION REFERS TO COMPOUNDS HAVING ANTI-INFLAMMATORY ACTIVITY CHARACTERIZED BY THE FORMULA OR A STEREOISOMERIC COMPONENT THEREOF, IN WHICH FORMULA X1 REPRESENTS A HYDROGEN, CHLORINE, BROMINE OR FLUORINE ATOM; X2 REPRESENTS A HYDROGEN, CHLORINE, BROMINE OR FLUORINE ATOM;R1 REPRESENTS A ?-HYDROXY GROUP, A ?-CHLORINE ATOM OR AN OXO GROUP; R2 REPRESENTS A HYDROGEN ATOM, A METHYLENE GROUP OR AN A- OR ?-METHYL GROUP;R3 REPRESENTS A HYDROGEN ATOM OR AN ACYL GROUP OF 1 THROUGH 8 CARBONS ATOMS; R4 REPRESENTS A HYDROGEN ATOM, A (C1-C5) ALKYL GROUP OR A PHENYLGROUP; R5 REPRESENTS A HYDROGEN ATOM, A (C1-C5) ALKYL GROUP OR A PHENYL GROUP;Y REPRESENTS EITHER CR7R8, O, S OR NR9, WHERE R7, R8 AND R9 ARE SELECTED FROM HYDROGEN OR FROM STRAIGHT OR BRANCHEDHYDROCARBON CHAINS HAVING 1-8 CARBON ATOMS OR FROM A PHENYL GROUP.R6 REPRESENT A HYDROGEN ATOM; A METHYL GROUP; A PHENYL OR AN ALKENYL OR CYCLOALKENYL GROUP OPTIONALLY SUBSTITUTED BY ALKYL,NITRO, CARBOXY, ALKOXY, HALOGEN, CYONA, CARBALKOXY AND TRIFLUOROMETHYL GROUP(S); A (C1-C5) ALKYL GROUP SUBSTITUTED BY AT LEAST ONE HALOGEN ATOM; A SATURATED OR UNSATURATED CARBOCYCLIC OR HETEROCYCLIC (O, S, N) RING SYSTEM CONTAINING 3-10 ATOMS IN THE RING SYSTEM; A C1 ALKYL GROUP SUBSTITUTED BY EITHER ONE OR TWO ALICYCLIC OR AROMATIC 3, 4, 5 OR 6-NUMBERED RING SYSTEM(S) OR ONE, TWO OR THREE STRAIGHT OR BRANCHED, SATURATED OR UNSATURATED HYDROCARBONS CHAINS HAVING 1 THROUGH 18 CARBON ATOMS; AND REPRESENTS A SINGLE OR DOUBLE BOND.THE INVENTION ALSO REFERS TO A PROCESS AND INTERMEDIATES FOR THE PREPARATION OF THESE COMPOUNDS, A PHARMACEUTICAL PREPARATION CONTAINING ONE OF THE COMPOUNDS A METHOD FOR THE TREATMENT OF INFLAMMATORY CONDITIONS. |
| priorityDate | 1985-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.